Integer Holdings Corporation (NYSE:ITGR – Get Free Report) insider Kirk Thor sold 11,767 shares of the company’s stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $126.23, for a total transaction of $1,485,348.41. Following the completion of the transaction, the insider owned 7,153 shares in the company, valued at approximately $902,923.19. This trade represents a 62.19% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.
Integer Stock Performance
ITGR stock traded up $0.01 during mid-day trading on Wednesday, hitting $126.22. 1,124,095 shares of the company were exchanged, compared to its average volume of 707,592. Integer Holdings Corporation has a 1-year low of $62.00 and a 1-year high of $126.79. The stock has a market capitalization of $4.29 billion, a PE ratio of 34.49, a price-to-earnings-growth ratio of 2.40 and a beta of 0.62. The business has a 50 day simple moving average of $116.25 and a 200-day simple moving average of $98.19. The company has a current ratio of 3.73, a quick ratio of 2.41 and a debt-to-equity ratio of 0.75.
Integer (NYSE:ITGR – Get Free Report) last issued its quarterly earnings data on Monday, August 3rd. The medical equipment provider reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.38 by $0.22. Integer had a return on equity of 12.79% and a net margin of 6.97%.The firm had revenue of $464.11 million for the quarter, compared to analyst estimates of $451.07 million. During the same period in the prior year, the firm posted $1.55 EPS. The company’s revenue for the quarter was down 2.6% on a year-over-year basis. On average, equities analysts forecast that Integer Holdings Corporation will post 6.09 earnings per share for the current year.
Institutional Investors Weigh In On Integer
Wall Street Analyst Weigh In
Several analysts have weighed in on ITGR shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Integer in a research note on Thursday, June 18th. Freedom Capital lowered shares of Integer from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 4th. Citigroup raised their target price on shares of Integer from $92.00 to $96.00 and gave the stock a “neutral” rating in a report on Wednesday, July 8th. Piper Sandler cut Integer from an “overweight” rating to a “hold” rating and set a $127.00 price target for the company. in a research note on Monday, August 3rd. Finally, Wells Fargo & Company increased their price target on Integer from $84.00 to $127.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 4th. One equities research analyst has rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $109.86.
View Our Latest Report on Integer
Integer Company Profile
Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.
Integer’s medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices.
Further Reading
- Five stocks we like better than Integer
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
